These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Determination of T- and B-lymphocyte functional activity and of the rosette formation phenomenon in Kaposi's angioreticulosis]. Reznikova LS, Stoianov VB. Vestn Dermatol Venerol; 1979 Jul; (7):14-7. PubMed ID: 314713 [No Abstract] [Full Text] [Related]
4. [Immune response in the course of Kaposi's sarcoma]. Scalise G, Mura MS, Piersimoni C, Manca S, Cherchi G, Andreoni G. Boll Ist Sieroter Milan; 1980 Jul; 59(6):632-7. PubMed ID: 7236363 [Abstract] [Full Text] [Related]
5. [Functional activity of the lymphocytes in patients with Kaposi's sarcoma]. Korneeva MN, Novokhatskiĭ AS, Grebeniuk VN, Kerimov SG. Vestn Dermatol Venerol; 1988 Jul; (3):32-6. PubMed ID: 3381581 [No Abstract] [Full Text] [Related]
7. [The immune status of patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma]. Faradzhev ZG, Derevnina NA, Ivshina AV. Vestn Dermatol Venerol; 1990 Mar; (1):16-20. PubMed ID: 2327165 [Abstract] [Full Text] [Related]
8. Histological and immunological features of primary Kaposi's sarcoma: evaluation before and after chemotherapy. Brambilla L, Boneschi V, Pigatto PD, Finzi AF, Marinig C, Renoldi P, Fiorini GF. Acta Derm Venereol; 1987 Mar; 67(3):211-7. PubMed ID: 2442933 [Abstract] [Full Text] [Related]
10. [Kaposi sarcoma and Hodgkin disease]. Pujol Marco C, Alegre de Miguel V, Camps Herrero C, Febrer Bosch I, Oliver Martínez V, Guillén Barona C, Fortea Baixauli JM. An Med Interna; 1989 May; 6(5):263-5. PubMed ID: 2491541 [Abstract] [Full Text] [Related]
13. [Disordered cell-receptor metabolism (R-proteins) and the immunity indices in patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma]. Faradzhev ZG, Samsonov VA, Bukhova VP. Vestn Dermatol Venerol; 1990 Sep 30; (10):17-20. PubMed ID: 2177582 [Abstract] [Full Text] [Related]
15. [The cytotoxic effect of the thrombocytes from patients with mycosis fungoides and Kaposi's sarcoma]. Faradzhev ZG, Bolvacheva AV, Bykovskaia SN. Vestn Dermatol Venerol; 1990 Sep 30; (11):34-6. PubMed ID: 2288150 [Abstract] [Full Text] [Related]
16. [Classical form of Kaposi sarcoma: immunology and interferon therapy]. Thiele B, Schuff-Werner P, Rahlf G, Mahrle G, Ippen H. Hautarzt; 1984 Jul 30; 35(7):349-53. PubMed ID: 6206024 [Abstract] [Full Text] [Related]
17. An immunohistological study of factor VIII related antigen and Kaposi's sarcoma using polyclonal and monoclonal antibodies. Millard PR, Heryet AR. J Pathol; 1985 May 30; 146(1):31-8. PubMed ID: 3925107 [Abstract] [Full Text] [Related]
19. [Anti-cytomegalovirus antibodies and Kaposi's sarcoma]. Veraldi S, Ferrante P, Barbi M, Mancuso R, Brambilla L, Marini D. G Ital Dermatol Venereol; 1988 Mar 30; 123(3):75-7. PubMed ID: 2842256 [No Abstract] [Full Text] [Related]
20. Kaposi's sarcoma and lymphoid neoplasia in the same lesion. Pizarro A, Baron JM. Arch Pathol Lab Med; 1992 Aug 30; 116(8):812-3. PubMed ID: 1497458 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]